Sustained Clinical Benefit of AAV Gene Therapy in Severe Hemophilia B
N Engl J Med. 2025 Jun 12;392(22):2226-2234. doi: 10.1056/NEJMoa2414783. ABSTRACT BACKGROUND: Adeno-associated virus (AAV)-mediated gene therapy has emerged as a promising treatment for hemophilia B. …